NCT01836094View on ClinicalTrials.gov

Effects of USP Methylene Blue on Cognitive and fMRI Brain Activity

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Brain Activity
Interventions
DRUG

Methylene Blue (USP grade, 280mg oral)

DRUG

Placebo

oral, one time

Trial Locations (1)

78229

Research Imaging Institute, The University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT01836094 - Effects of USP Methylene Blue on Cognitive and fMRI Brain Activity | Biotech Hunter | Biotech Hunter